Vancouver, British Columbia–(Newsfile Corp. – May 4, 2021) – Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“ Lobe” or the “Company“) is pleased to announce that it has acquired, through its wholly owned subsidiary Eleusian Biosciences Corp. (“Eleusian“), the consumer goods product line, “Vitamind”, pursuant to an asset purchase agreement (the “Purchase Agreement“) dated April 30…


Previous articlePT242 – Gary Laderman – Religion: Sex, Death, and Drugs
Next articleOptimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol